The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

Muenchow, Alina; Weller, Sandra; Hinterleitner, Clemens; Malenke, Elke; Bugl, Stefanie; Wirths, Stefan; Mueller, Martin R.; Schulze-Osthoff, Klaus; Aulitzky, Walter E.; Kopp, Hans-Georg; Essmann, Frank

dc.contributor.author	Weller, Sandra
dc.contributor.author	Hinterleitner, Clemens
dc.contributor.author	Malenke, Elke
dc.contributor.author	Bugl, Stefanie
dc.contributor.author	Wirths, Stefan
dc.contributor.author	Schulze-Osthoff, Klaus
dc.contributor.author	Kopp, Hans-Georg
dc.contributor.author	Essmann, Frank
dc.contributor.author	Müller, Martin Rudolf
dc.date.accessioned	2020-12-14T11:17:23Z
dc.date.available	2020-12-14T11:17:23Z
dc.date.issued	2020
dc.identifier.issn	2041-4889
dc.identifier.uri	http://hdl.handle.net/10900/110615
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41419-020-02910-2	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200929220116_00175
utue.personen.roh	Muenchow, Alina
utue.personen.roh	Weller, Sandra
utue.personen.roh	Hinterleitner, Clemens
utue.personen.roh	Malenke, Elke
utue.personen.roh	Bugl, Stefanie
utue.personen.roh	Wirths, Stefan
utue.personen.roh	Mueller, Martin R.
utue.personen.roh	Schulze-Osthoff, Klaus
utue.personen.roh	Aulitzky, Walter E.
utue.personen.roh	Kopp, Hans-Georg
utue.personen.roh	Essmann, Frank
dcterms.isPartOf.ZSTitelID	Cell Death & Disease	de_DE
dcterms.isPartOf.ZS-Issue	Article 701	de_DE
dcterms.isPartOf.ZS-Volume	11	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE